Table of Content

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Burden of Lung Cancer
4.2.2 Technological Advancements in the Field of Minimally Invasive Surgeries
4.2.3 Rise in the Level of Air Pollution
4.3 Market Restraints
4.3.1 Effective Alternative Treatment
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Type
5.1.1 Thoracotomy
5.1.1.1 Lobectomy
5.1.1.2 Sleeve Resection
5.1.1.3 Segmentectomy
5.1.1.4 Pneumonectomy
5.1.2 Minimally Invasive Surgeries
5.2 By Product
5.2.1 Surgical Devices
5.2.2 Monitoring Devices
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Accuray Incorporated
6.1.2 GE Healthcare
6.1.3 Johnson & Johnson
6.1.4 Olympus Corporation
6.1.5 Richard Wolf GmbH
6.1.6 Siemens Healthineers AG
6.1.7 AngioDynamics Inc.


7 MARKET OPPORTUNITIES AND FUTURE TRENDS